citalopram has been researched along with 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aznar, S; El-Sayed, M; Elvang, AB; Ettrup, A; Holm, P; Klein, AB; Knudsen, GM; Mikkelsen, JD; Santini, MA; Stensbøl, TB | 1 |
Benzinger, T; Cirrito, JR; D'Angelo, G; Disabato, BM; Goebel, WD; Hayreh, D; Kim, J; Mintun, MA; Morris, JC; Restivo, JL; Sathyan, A; Sheline, YI; Verges, DK; Yoon, H | 1 |
2 other study(ies) available for citalopram and 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
Article | Year |
---|---|
Plaque deposition dependent decrease in 5-HT2A serotonin receptor in AbetaPPswe/PS1dE9 amyloid overexpressing mice.
Topics: Aging; Amphetamines; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Autoradiography; Citalopram; Data Interpretation, Statistical; Fluorobenzenes; Genes, fos; Head Movements; Humans; In Situ Hybridization; Indicators and Reagents; Male; Mice; Mice, Transgenic; Piperidines; Plaque, Amyloid; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles | 2010 |
Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Antidepressive Agents, Second-Generation; Brain; Citalopram; Female; Humans; Male; Mice; Mice, Transgenic; Positron-Emission Tomography; Radiography; Serotonin; Signal Transduction; Thiazoles; Time Factors | 2011 |